FDA cancels pivotal advisory meeting about next season's flu vaccine
FDA cancels meeting to select flu strains for next season's shots
 · 3dhealth.wusf.usf.edu
The FDA has canceled an important upcoming meeting about vaccines
The FDA's Vaccines and Related Biological Products Advisory Committee was scheduled for next month. But the agency notified committee members that the meeting had been canceled.
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the end to the booming market for cheaper versions made by pharmacies.
Exclusive: FDA staffers told that 'woman,' 'disabled' among banned words; White House says it’s an error
A list with the file name "Prohibited words" has been circulating since at least last week in official work chats, according to two FDA scientists with direct knowledge of the matter.
Trump Administration Reverses Layoffs At These Federal Agencies—After Cutting Bird Flu, FDA Staff
Some employees at the National Nuclear Security Administration, which oversees the U.S.’ nuclear weapons, were reportedly summoned back to work after being laid off.
CDC: Bad flu season has peaked in the United States
One of the worst flu seasons in years has reached its peak and is improving, officials with the Centers for Disease Control and Prevention announced Friday.
Abortion pill maker enters legal battle over FDA rules
The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure since President Trump returned to office.  The company, GenBioPro,
JD Supra7d
FDA Continues Push to Improve Food Labeling Practices in the United States
In September 2022, former President Biden convened the White House Conference on Hunger, Nutrition, and Health, during which the White
Cure Today8h
FDA Accepts Ordspono Resubmission in R/R Follicular Lymphoma Treatment
The FDA has accepted the resubmission of the BLA of Ordspono for review in relapsed/refractory follicular lymphoma following previous systemic therapy.
Morningstar7d
United States FDA Approves NM8074 (Ruxoprubart) IND for Treating Dermatomyositis (DM): A Chronic Inflammatory Disorder of the Skin
The United States FDA Approves the Initiation for Phase II Efficacy Trial in Dermatomyositis (DM) Patients: A Skin & Muscle Disorder CLEVELAND, Feb. 24, 2025 (GLOBE NEWSWIRE) -- NovelMed ...